Please login to the form below
How do you ensure your communication will excite and interest your patients
This is an opinion article on how to keep your patients interested and on board through the full clinical study
Most trials now have patients of
all ages in many countries, who expect to have all the information available in
a range of formats, in hard copy and electronically on their smartphones and
tablets. Consequently, multi-media content in your patients’ own languages is a
must for successful clinical trial communication.
So what is the best way to keep a group of 10 to 16 year old patients engaged throughout a two year clinical trial? Ask them to fill in a paper diary written in English? Any parents of teenagers reading this will probably empathise with the regular challenge of getting kids to do their homework in their school books rather than spend their evenings chatting with their mates online and playing the likes of Minecraft on their games consoles. A recent brilliant solution was to use a computer game to gather the feedback from the teenage patients, with more levels released on continued patient engagement. The compliance levels were massively improved.
Those in the marketing world are breaking down the traditional lines of communication – there is no longer a division between digital and hard copy marketing, just a spectrum of relevant media with the chosen means of contact tailored to the target audience. The same trends for engagement can be followed by those in the clinical trials industry when communicating with patients.
As well as engaging with patients using media they feel comfortable with, it makes perfect sense to partner this approach with the translation of clinical material into languages that patients understand.
There are challenges involved in translating multimedia files and software apps, including separating the translatable text from the background coding, transcription, dubbing, layout editing and typesetting. Choosing a translation expert with the tools and expertise to manage these technical challenges is the first step to successful patient engagement.
Multi-lingual, multimedia content is essential for successful clinical trial communication. Overcoming the associated challenges in expanding your technical and linguistic capabilities is well worth the effort.
Dr Mark Hooper is a director at Conversis Medical. For more information visit conversis.com
![]()
So what is the best way to keep a group of 10 to 16 year old patients engaged throughout a two year clinical trial? Ask them to fill in a paper diary written in English? Any parents of teenagers reading this will probably empathise with the regular challenge of getting kids to do their homework in their school books rather than spend their evenings chatting with their mates online and playing the likes of Minecraft on their games consoles. A recent brilliant solution was to use a computer game to gather the feedback from the teenage patients, with more levels released on continued patient engagement. The compliance levels were massively improved.
Those in the marketing world are breaking down the traditional lines of communication – there is no longer a division between digital and hard copy marketing, just a spectrum of relevant media with the chosen means of contact tailored to the target audience. The same trends for engagement can be followed by those in the clinical trials industry when communicating with patients.
As well as engaging with patients using media they feel comfortable with, it makes perfect sense to partner this approach with the translation of clinical material into languages that patients understand.
There are challenges involved in translating multimedia files and software apps, including separating the translatable text from the background coding, transcription, dubbing, layout editing and typesetting. Choosing a translation expert with the tools and expertise to manage these technical challenges is the first step to successful patient engagement.
Multi-lingual, multimedia content is essential for successful clinical trial communication. Overcoming the associated challenges in expanding your technical and linguistic capabilities is well worth the effort.
Dr Mark Hooper is a director at Conversis Medical. For more information visit conversis.com
Company Details
Conversis
+44 (0)1869255820
Address:
Bignell Park Barns
Chesterton
Bicester
Oxfordshire
OX26 1TD
United Kingdom
Latest content on this profile
- Medical Translations: Why you need to get it right the first time
- British and American senior medical executives admit to image and reputation being at risk because of misinterpreted cultural references or linguistic errors.
Conversis
- Avoiding PR Disaster: Cultural Customisation
Conversis
- 10 tips on Transcreation
- We have put together a few pointers that you should consider for the process of transcreation.
Conversis
- Top 10 tips for Translation in Medical Communications
- Accuracy and high-quality should be the most important decision factors when choosing your medical translations partner as there is no room for mistakes or ambiguities.
Conversis
- How do you ensure your communication will excite and interest your patients
- This is an opinion article on how to keep your patients interested and on board through the full clinical study
Conversis
- What it takes to win at Cannes Health Lions
- A podcast featuring our Director, Russell Goldsmith, talking with two judges of the Lions Health Awards, Zuleika Burnett, Executive Director for Creative and Innovation at Havas Life Medicom and Martin Hafley, Creative Director at DDB Remedy London, together with a past Bronze winner, Khalid Latiff, Associate Creative Director at Publicis Life Brands Resolute (PLBR), whose company also picked up a Silver and Bronze this year too.
Conversis
